The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI.

Cushnie, Adriana K; Bullock, Daniel N; Manea, Ana M G; Tang, Wei; Zimmermann, Jan; Heilbronner, Sarah R.

Cushnie AK; Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA.
Bullock DN; Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA.
Manea AMG; Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA.
Tang W; Department of Computer Science, Program in Neuroscience, Indiana University Bloomington, Bloomington, IN, 47408, USA.
Zimmermann J; Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA.
Heilbronner SR; Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, MN, 55455, USA.

Curr Res Neurobiol ; 4: 100072, 2023.

Article en En | MEDLINE | ID: mdl-36691404

Palabras clave

CLZ, Clozapine; DCZ, Deschloroclozapine; DREADDs, Designer Receptors Exclusively Activated by Designer Drugs; INTs, Intrinsic Neural Timescales; NHP, Nonhuman Primate; rs-FC, Resting-State Functional Connectivity; rs-fMRI, Resting-State Functional Magnetic Resonance Imaging

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article